S. Kalandakanond et Ja. Coffield, Cleavage of intracellular substrates of botulinum toxins A, C, and D in a mammalian target tissue, J PHARM EXP, 296(3), 2001, pp. 749-755
Citations number
40
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
The objective of the current study was to determine whether the intracellul
ar targets that mediate the mechanism of action of botulinum toxin at the m
ammalian neuromuscular junction are the same as those identified in nontarg
et tissues. Previous studies of this nature have been limited to nontarget
tissues because of the perceived low abundance of neural proteins in a neur
omuscular preparation. In the current study we have used differential centr
ifugation to concentrate neural proteins in a synaptosomal-enriched fractio
n from the mouse phrenic nerve-hemidiaphragm preparation. Immunoblot detect
ion revealed the presence of discrete immunoreactive bands corresponding to
SNAP-25, synaptobrevin II, and syntaxin I in the innervated region of the
neuromuscular preparation. The ability of these proteins to serve as botuli
num toxin substrates in neuromuscular tissue was determined by measuring to
xin-induced proteolysis. Exposure of the intact hemidiaphragm preparation t
o botulinum serotypes A, C, and D (10(-8) M, 5-6-h exposure) resulted in si
gnificant reductions in SNAP-25 (67%), syntaxin I (56%), and synaptobrevin
II (72%) immunoreactivity, respectively. The toxin-induced proteolysis was
specific for each serotype examined. Collectively, these findings provide d
irect confirmation that botulinum toxin targets integral components of the
molecular machinery mediating neurotransmitter release at the neuromuscular
junction. To the best of our knowledge this is the first time that studies
of this nature on the intracellular action of botulinum toxin have been ex
tended to a recognized mammalian target tissue preparation.